Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
As shown in Table 2, a 10 ng/ml increase in 25(OH)D was associated with higher odds of having a CTD diagnosis when compared to the unaffected cohort (OR 2.08, 95% CI 1.27 to 3.42, p < 0.01).
Source: Levels of 25(OH)D and prevalence of hypovitaminosis D in CTD, unaffected, and tic onset cohort. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This cross-sectional study compared serum 25-hydroxyvitamin D [25(OH)D] (ng/ml) levels among three groups: children and adolescents (3 to 16 years) with CTD (n = 327); first-degree relatives (3 to 10 years) of individuals with CTD who were assessed for a period of up to 7 years for possible onset of tics and developed tics within this period (n = 31); and first-degree relatives who did not develop tics and were ≥ 10 years old at their last assessment (n = 93).
Source: Abstract.
Participants were from the European Multicentre Tics in Children Studies (EMTICS) [], a prospective longitudinal observational study involving 16 centres located in nine countries across Europe and in Israel.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study
Cross-sectional study · European Child & Adolescent Psychiatry · 2021
Original publication title
Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study
© The Author(s) 2021
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
This study investigated whether vitamin D is associated with the presence or severity of chronic tic disorders and their psychiatric comorbidities. This cross-sectional study compared serum 25-hydroxyvitamin D [25(OH)D] (ng/ml) levels among three groups: children and adolescents (3 to 16 years) with CTD (n = 327); first-degree relatives (3 to 10 years) of individuals with CTD who were assessed for a period of up to 7 years for possible onset of tics and developed tics within this period (n = 31); and first-degree relatives who did not develop tics and were ≥ 10 years old at their last assessment (n = 93).
The relationship between 25(OH)D and the presence and severity of tics, as well as comorbid obsessive: compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD), were analysed controlling for age, sex, season, centre, latitude, family relatedness, and comorbidities. When comparing the CTD cohort to the unaffected cohort, the observed result was contrary to the one expected: a 10 ng/ml increase in 25(OH)D was associated with higher odds of having CTD (OR 2.08, 95% CI 1.27 to 3.42, p < 0.01). There was no association between 25(OH)D and tic severity.
However, a 10 ng/ml increase in 25(OH)D was associated with lower odds of having comorbid ADHD within the CTD cohort (OR 0.55, 95% CI 0.36 to 0.84, p = 0.01) and was inversely associated with ADHD symptom severity (β = − 2.52, 95% CI − 4.16 to 0.88, p < 0.01). In conclusion, lower vitamin D levels were not associated with a higher presence or severity of tics but were associated with the presence and severity of comorbid ADHD in children and adolescents with CTD.
Authors’ abstract
This study investigated whether vitamin D is associated with the presence or severity of chronic tic disorders and their psychiatric comorbidities. This cross-sectional study compared serum 25-hydroxyvitamin D [25(OH)D] (ng/ml) levels among three groups: children and adolescents (3 to 16 years) with CTD (n = 327); first-degree relatives (3 to 10 years) of individuals with CTD who were assessed for a period of up to 7 years for possible onset of tics and developed tics within this period (n = 31); and first-degree relatives who did not develop tics and were ≥ 10 years old at their last assessment (n = 93).
The relationship between 25(OH)D and the presence and severity of tics, as well as comorbid obsessive: compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD), were analysed controlling for age, sex, season, centre, latitude, family relatedness, and comorbidities. When comparing the CTD cohort to the unaffected cohort, the observed result was contrary to the one expected: a 10 ng/ml increase in 25(OH)D was associated with higher odds of having CTD (OR 2.08, 95% CI 1.27 to 3.42, p < 0.01). There was no association between 25(OH)D and tic severity.
However, a 10 ng/ml increase in 25(OH)D was associated with lower odds of having comorbid ADHD within the CTD cohort (OR 0.55, 95% CI 0.36 to 0.84, p = 0.01) and was inversely associated with ADHD symptom severity (β = − 2.52, 95% CI − 4.16 to 0.88, p < 0.01). In conclusion, lower vitamin D levels were not associated with a higher presence or severity of tics but were associated with the presence and severity of comorbid ADHD in children and adolescents with CTD.
Publication and source details
Original title: Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study
Molly Bond; Natalie Moll; Alicia Rosello; Rod Bond; Jaana Schnell; Bianka Burger; Pieter J. Hoekstra; Andrea Dietrich; Anette Schrag; Eva Kocovska; Davide Martino; Norbert Mueller; Markus Schwarz; Ute-Christiane Meier; the EMTICS Collaborative GroupBruunJulie E.GrejsenJudyOmmundsenChristine L.RubækMetteEnghardtStephanieBokemeyerStefanieDriedger-GarbeChristianeReichertCorneliaSchmalfeldJennyDuffieldThomasGergyeFranciskaKovacsMargitVidomuszRekaCarmelMiriFennigSilvanaGevEllaKellerNathanMichaelovskyElenaNahonMatanRegevChenSimchaTomerSmollanGillWeizmanAviGagliardiGiuseppeTallonMarcoRoazziPaolovan den BanElsde BruijnSebastian F. T. M.DriessenNicoleLamerzAndreasMesschendorpMariekeRathJudith J. G.SivalNadine Schalk DeborahTrompNoorVisscherFrankde la TourettesStichting GillesCáceresMaria TeresaCarrilloFátimaGómez-GarrePilarVargasLauraGariupMariaStöberSaraApterAlanBaglioniValentinaBallJulianeBenaroya-MilshteinNoaBodmerBenjaminhttp://orcid.org/0000-0003-4406-8990BondMollyBognarEmeseBurgerBiankaBuseJudithCardonaFrancescoVelaMarta CorreaDietrichAndreaDebesNanette M.FerroMaria CristinaFremerCarolinGarcia-DelgarBlancaGulisanoMariangelaHagenAnneliekeHagstrømJulieHedderlyTammy J.HeymanIsobelHoekstraPieter J.HuyserChaimMadruga-GarridoMarcosMarottaAnnaMartinoDavideMeierUte-ChristianeMirPabloMollNatalieMorerAstridMuellerNorbertMüller-VahlKirstenMünchauAlexanderNagyPeterNeriValeriaOpenneerThaïra J. C.PellicoAlessandraVascoÁngela PeriañezPlessenKerstin J.PorcelliCesareRedondoMarinaRizzoRenataRoessnerVeitRuhrmanDaphnaSchnellJaana M. L.SchragAnetteSchwarzMarcus J.SilvestriPaola RosariaSkovLiselotteSteinbergTamarGloorFriederike TagwerkerTarnokZsanettTübingJenniferTurnerVictoria L.WalitzaSusanneWeidingerElifWoodsMartin L.
European Child & Adolescent Psychiatry · 2021
© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100004963Seventh Framework Programme278367Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:35:23.852354+00:00
DOI: 10.1007/s00787-021-01757-y · PMC9343310